Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in Obesity
Authors:
Open Access
- 1 May 2012
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (5) , 1655-1662
Abstract
Background: Obesity is associated with hyperparathyroidism and increased bone mass and turnover, but their pathogeneses are unclear. Aims: Our aim was to determine in obesity interrelationships among serum levels of leptin, the mineral-regulating hormones, bone turnover markers, and sclerostin. Methods: This case-control study was performed in 20 women having bariatric surgery and 20 control women matched for race and age. Anthropometrics and fasting serum biochemistries were measured in controls and in bariatric patients the morning of surgery. Results: Body mass index (48.9 vs. 25.4 kg/m2), weight (128.6 vs. 71.9 kg), serum leptin (74.6 vs. 25.2 ng/ml), PTH (44.5 vs. 28.8 pg/ml), fibroblast growth factor 23 (FGF23) (42.4 vs. 25.9 pg/ml), and bone alkaline phosphatase (BAP) (25.8 vs. 17.5 U/liter) were higher, but height (162.3 vs. 167.7 cm) and 1,25-dihydroxyvitamin D (1,25D) (39.2 vs. 48.7 pg/ml) were lower in bariatric surgery patients than controls. There was no difference in serum sclerostin, amino-terminal collagen cross-links, 25-hydroxyvitamin D (25D), calcium, phosphate, and creatinine between groups. In the combined sample, leptin was positively related to PTH, FGF23, and BAP but not to 1,25D or sclerostin. Multiple regression analysis demonstrated that PTH was predicted by leptin and Ca (R2 = 0.39); 1,25D by 25D, FGF23, and phosphate (R2 = 0.43); FGF23 by leptin and 1,25D (R2 = 0.27); BAP by leptin, PTH, and Ca (R2 = 0.39); and sclerostin by leptin and PTH (R2 = 0.20). Conclusions: Women having bariatric surgery had higher leptin, PTH, FGF23, and BAP and lower 1,25D than controls. Leptin predicted the serum levels of PTH, 1,25D, and FGF23, the mineral-regulating hormones, and BAP, a bone formation marker, in women with body mass index ranging from 13.9–65.8 kg/m2. The results suggest that leptin has an endocrine or paracrine effect on PTH and FGF23 production and that PTH may be one of the signals in obesity that leads to increased bone mass.Keywords
This publication has 53 references indexed in Scilit:
- Vitamin D and Hyperparathyroidism in ObesityThe Journal of Clinical Endocrinology & Metabolism, 2011
- Severe Obesity Is Associated with Symptomatic Presentation, Higher Parathyroid Hormone Levels, and Increased Gland Weight in Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2010
- Adipokines as novel biomarkers and regulators of the metabolic syndromeAnnals of the New York Academy of Sciences, 2010
- Leptin: The link between overweight and primary hyperparathyroidism?Medical Hypotheses, 2010
- The association of adiposity with parathyroid hormone in healthy older adultsEndocrine, 2009
- Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment studyClinical Endocrinology, 2009
- Mechanobiology of the SkeletonA presentation from the Keystone Symposium Mechanotransduction in Physiology and Disease in Taos, New Mexico, 18 to 23 January 2009.Science Signaling, 2009
- Control of Bone Mass and Remodeling by PTH Receptor Signaling in OsteocytesPLOS ONE, 2008
- Osteocytes, mechanosensing and Wnt signalingBone, 2008
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004